Contact
searchSearch
HMP Global

Conference Coverage

wells
Clinical Insights
Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
Blauvelt
Clinical Insights
Transforming Psoriasis Care: Oral IL-23 Therapy and the Next Frontier in Patient-Centered Treatment
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that...
03/02/2026
The Dermatologist
Werth
Clinical Insights
Advances in Dermatomyositis: The Evolving Landscape and Potential Role of Novel Therapies to Improve Disease Outcomes
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic...
03/02/2026
The Dermatologist
Gottlieb
Clinical Insights
Reimagining Hidradenitis Suppurativa Care: Early Recognition, Therapeutic Innovation, and Multidisciplinary Care Across the Patient Journey
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion,...
03/02/2026
The Dermatologist
Asempa
Clinical Insights
Advancing Inclusive Outcome Measures in Dermatology
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr...
03/02/2026
The Dermatologist
Krueger
Clinical Insights
Advancing Oral Therapies in Psoriasis: Targeted Innovation for Improved Disease Control and Patient Adherence
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr...
03/02/2026
The Dermatologist
Yosipovitch
Clinical Insights
Rapid Neuromodulation and Mast Cell Targeting in Chronic Pruritus
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that...
03/02/2026
The Dermatologist
Yoo
Clinical Insights
Ultrasound as a Transformative Tool in Dermatology: From Cosmetic Imaging to Hidradenitis Suppurativa Assessment and Emerging Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed...
03/02/2026
The Dermatologist
Dr Heberton
Conference Coverage
Checkpoint Inhibitor Rashes: When to Treat, When to Rechallenge, and When It’s Not the Drug
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous...
02/22/2026
The Dermatologist
Dr Heberton
Conference Coverage
EGFR Inhibitor Rashes: Prophylaxis, Isotretinoin, and When to Culture
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous...
02/22/2026
The Dermatologist

Popular Articles

Shilpi Khetarpal-2024
Podcasts
Diversifying Dermatologic Care: Unmet Needs & Challenges
03/21/2024
Shilpi Khetarpal, MD, FAAD
In this podcast, Dr Shilpi Khetarpal delve into the challenges and opportunities in providing dermatological care to diverse populations.
In this podcast, Dr Shilpi Khetarpal delve into the challenges and opportunities in providing dermatological care to diverse populations.
In this podcast, Dr Shilpi...
03/21/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Jessica Garlewicz; Riya Gandhi, MA
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
Spotlight
A Conversation With Abraham M. Korman, MD
06/06/2024
Benjamin Barankin, MD, FRCPC
Dr Korman is an assistant professor in the department of dermatology at the Ohio State University Wexner Medical Center.
Dr Korman is an assistant professor in the department of dermatology at the Ohio State University Wexner Medical Center.
Dr Korman is an assistant...
06/06/2024
The Dermatologist
psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Jessica Garlewicz
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
Feature Story
Broadening Definitions: What Constitutes a Natural or Organic Treatment?
09/06/2024
Steven R. Feldman, MD, PhD; Sarah L. Taylor, MD, MPH, BS ; Tom Soker, MD; Matthew L. Melton, MD
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural...
09/06/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use